| Literature DB >> 33322016 |
Federica Porcaro1, Nicola Ullmann1, Annalisa Allegorico1, Antonio Di Marco1, Renato Cutrera1.
Abstract
Asthma is the most frequent chronic inflammatory disease of the lower airways affecting children, and it can still be considered a challenge for pediatricians. Although most asthmatic patients are symptom-free with standard treatments, a small percentage of them suffer from uncontrolled persistent asthma. In these children, a multidisciplinary systematic assessment, including comorbidities, treatment-related issues, environmental exposures, and psychosocial factors is needed. The identification of modifiable factors is important to differentiate children with difficult asthma from those with true severe therapy-resistant asthma. Early intervention on modifiable factors for children with difficult asthma allows for better control of asthma without the need for invasive investigation and further escalation of treatment. Otherwise, addressing a correct diagnosis of true severe therapy-resistant asthma avoids diagnostic and therapeutic delays, allowing patients to benefit from using new and advanced biological therapies.Entities:
Keywords: asthma; biologic drugs; children; difficult asthma; severe asthma
Year: 2020 PMID: 33322016 PMCID: PMC7764801 DOI: 10.3390/children7120286
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067